Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anapsos placebo-controlled trial for moderate atopic dermatitis in children and adolescents
2008-006422-33Phase 4Active
- Sponsor
- Centrum
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Anapsos with Placebo (2 arms). Primary endpoints: Percentage of days using topical corticosteroids during 6 months and Number of days per month requiring topical glucocorticoids. Started May 2009; status: active.
02
Drugs
Polypodium leucotomos
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2008-006422-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006422-33.